alpha-acetamido-n-benzyl-alpha-(furan-2-yl)acetamide has been researched along with safinamide in 1 studies
Studies (alpha-acetamido-n-benzyl-alpha-(furan-2-yl)acetamide) | Trials (alpha-acetamido-n-benzyl-alpha-(furan-2-yl)acetamide) | Recent Studies (post-2010) (alpha-acetamido-n-benzyl-alpha-(furan-2-yl)acetamide) | Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) |
---|---|---|---|---|---|
7 | 0 | 1 | 199 | 29 | 159 |
Protein | Taxonomy | alpha-acetamido-n-benzyl-alpha-(furan-2-yl)acetamide (IC50) | safinamide (IC50) |
---|---|---|---|
Cholinesterase | Homo sapiens (human) | 0.0052 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.021 | |
Amine oxidase [flavin-containing] B | Rattus norvegicus (Norway rat) | 0.1 | |
Amine oxidase [flavin-containing] A | Rattus norvegicus (Norway rat) | 2.8 | |
Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.03 | |
Adenosine receptor A1 | Rattus norvegicus (Norway rat) | 0.0258 | |
Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.2406 | |
Renin | Callithrix jacchus (white-tufted-ear marmoset) | 0.08 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kohn, H; Salomé, C; Salomé-Grosjean, E; Stables, JP | 1 |
1 other study(ies) available for alpha-acetamido-n-benzyl-alpha-(furan-2-yl)acetamide and safinamide
Article | Year |
---|---|
Merging the structural motifs of functionalized amino acids and alpha-aminoamides: compounds with significant anticonvulsant activities.
Topics: Acetamides; Alanine; Amides; Amino Acids; Animals; Anticonvulsants; Benzylamines; Drug Evaluation, Preclinical; Lacosamide; Mice; Pain; Rats; Seizures; Structure-Activity Relationship; Treatment Outcome | 2010 |